Cingulate Inc. - stock earnings
CING Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -6.0 million USD | ? USD |
| 2023Q2 | -6.6 million USD | ? USD |
| 2023Q1 | -159.1 million USD | 3.8 billion USD |
| 2022Q4 | -765983 USD | ? USD |
| 2022Q3 | -4.1 million USD | ? USD |
| 2022Q2 | -4.0 million USD | ? USD |
| 2022Q1 | -5.0 million USD | ? USD |
| 2021Q4 | -2.7 million USD | ? USD |
| 2021Q3 | -15.3 million USD | ? USD |
| 2021Q2 | -1.4 million USD | ? USD |
| 2021Q1 | -1.3 million USD | ? USD |
| 2020Q4 | -1.2 million USD | ? USD |
| 2020Q3 | -1.1 million USD | ? USD |
CING Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.2 million USD | ? USD |
| 2022 | -17.9 million USD | ? USD |
| 2021 | -20.7 million USD | ? USD |
| 2020 | -7.3 million USD | ? USD |
| 2019 | -11.4 million USD | ? USD |
CING
Price: $1.15
52 week price:
Earnings Per Share: -26.00 USD
P/E Ratio: -0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 16900
Market Capitalization: 4.6 million